蘇大維格(300331.SZ)子公司獲得羣創光電供應商資格
格隆匯8月22日丨蘇大維格(300331.SZ)宣佈,公司接到全資子公司蘇州維旺科技有限公司(“維旺科技)通知,維旺科技於近日獲得“富士康科技集團”旗下面板廠商羣創光電股份有限公司(“羣創光電”)供應商資格,具備向其出售導光產品的資質。
羣創光電是面板行業全球知名企業,總部位於台灣並在台上市。羣創光電擁有3.5G-8.6G完整世代生產線,擁有完整的大中小尺寸LCD面板生產能力,其生產基地及銷售網絡遍佈全球,產品供應全球頂尖資訊與消費電子客户,為世界TFT-LCD領導廠商。
此次,公司全資子公司維旺科技獲得羣創光電供應商資格,充分體現了維旺科技在導光行業中的技術領先地位與競爭優勢,有助於維旺科技導光產品進入國際市場,對公司未來的業務拓展具有積極的推動作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.